Alethea Capital Management’s Eastman Chemical EMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-4,500
Closed -$525K 92
2021
Q2
$525K Hold
4,500
0.33% 50
2021
Q1
$496K Hold
4,500
0.3% 52
2020
Q4
$451K Hold
4,500
0.23% 50
2020
Q3
$352K Hold
4,500
0.24% 50
2020
Q2
$313K Buy
+4,500
New +$284K 0.18% 68
2020
Q1
Sell
-3,000
Closed -$238K 86
2019
Q4
$238K Hold
3,000
0.1% 76
2019
Q3
$221K Sell
3,000
-13,543
-82% -$972K 0.14% 76
2019
Q2
$1.29M Buy
+16,543
New +$1.26M 0.84% 9
2016
Q4
Sell
-30,158
Closed -$2.04M 78
2016
Q3
$2.04M Buy
+30,158
New +$2.02M 2.83% 8

Other funds holding EMN

Alethea Capital Management's EMN Position: Q3 2021 in Review

Alethea Capital Management sold out of Eastman Chemical (EMN) in Q3 2021, closing a stake of 4,500 shares — an estimated $525K sold.

Alethea Capital Management first reported a position in EMN in Q3 2016 and held it in 9 quarters. The position peaked at $2.04M in Q3 2016. 705 funds tracked by Wall St. Rank hold EMN as of Q3 2021.

  • Alethea Capital Management reported no remaining Eastman Chemical position as of Q3 2021 after selling out during the quarter.
  • Alethea Capital Management sold 4,500 Eastman Chemical shares in Q3 2021, an estimated $525K.
  • Alethea Capital Management first reported a position in Eastman Chemical in Q3 2016 and held it in 9 quarters.
  • Alethea Capital Management's Eastman Chemical position peaked at $2.04M in Q3 2016.
  • 705 funds tracked by Wall St. Rank held Eastman Chemical as of Q3 2021.

Based on Alethea Capital Management's 13F filing for Q3 2021, filed 27 Oct 2021.